The Genetic and Molecular Analyses of Rare Candidate Germline BRIP1/FANCJ Variants Implicated in Hereditary Breast and Ovarian Cancers
Authors:
- Wejdan M. AleneziWAWejdan M. Alenezi
- Larissa MilanoLMLarissa Milano
- Caitlin T. FierhellerCFCaitlin T. Fierheller
- Corinne SerruyaCSCorinne Serruya
- Timothée RevilTRTimothée Revil
- Kathleen K. OrosKOKathleen K. Oros
- Jeffrey P. BruceJBJeffrey P. Bruce
- Dan SpiegelmanDSDan Spiegelman
- Trevor PughTPTrevor Pugh
- Anne-Marie Mes-MassonAMAnne-Marie Mes-Masson
- Diane ProvencherDPDiane Provencher
- William D. FoulkesWFWilliam D. Foulkes
Open Access
- 20 January 2026
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 1037
Abstract
Five rare variants in BRIP1/FANCJ, initially identified in ovarian cancer (OC) or breast cancer (BC) cases by the adult hereditary cancer clinics, were investigated for their candidacy as clinically relevant variants. These variants were investigated genetically in a population exhibiting genetic drift and molecularly assayed for biological impact. Using in silico tools, population-based genetic databases and other resources, three of the five reported BRIP1 variants were likely to be damaging: c.797C>T; p.Thr266Met, c.2087C>T; p.Pro696Leu and c.2990_2993delCAAA; p.Thr997ArgfsTer61. The carrier frequencies ranged from 0 to 0.7% in ancestry-defined cancer groups comprising 47 OC families, 49 hereditary breast and ovarian cancer syndrome families, 142 hereditary breast cancer syndrome families, 435 sporadic OC cases and 563 sporadic BC cases and 0–0.2% in 1025 population-matched controls. Multiple carriers of the these variants were identified in additional population-matched cancer cases. Of the five reported BRIP1 variants, p.Thr266Met, p.Pro696Leu and c.2990_2993delCAAA; p.Thr997ArgfsTer61, which were predicted to be damaging, conferred cellular sensitivity to mitomycin C and cisplatin unlike p.Ser139Ala and p.Ala406Ser. Collectively, our investigation implicates BRIP1 c.797C>T; p.Thr266Met, c.2087C>T; p.Pro696Leu and c.2990_2993delCAAA; p.Thr997ArgfsTer61 as deleterious variants in OC and BC.Keywords
Funding Information
- the Canadian Institute for Health Research (PJT-156124)
- Saudi Arabian Cultural Bureau
- Department of Medicine, McGill University
- the Fond de la recherche du Québec en santé
- Quebec Breast Cancer Foundation network
- Compute Canada resource allocation project wst-164 and Genome Canada Genome Technology Platform
- CIHR foundation (PJT-517664)
- Santé (20697)
- Canadian Institutes of Health Research (MOP-115071)
- Canadian Institutes of Health Research (PJT-152989)
- Canadian Institutes of Health Research (PJT-190076)
- American Diabetes Association (1-15-ACE-26)
- FRSQ, McGill University and Université de Sherbrooke
- Banque de tissus et de données of the Réseau de recherche sur le cancer of the FRQS affiliated with the Canadian Tumour Repository Network
- Taibah University Scholarship
- RI-MUHC Scholarship Award
- James O and Maria Meadows Award
This publication has 149 references indexed in Scilit:
- Germline variants of homology‐directed repair or mismatch repair genes in cervical cancerInternational Journal of Cancer, 2024
- Genetic landscape of homologous recombination repair genes in early‐onset/familial prostate cancer patientsGenes, Chromosomes and Cancer, 2023
- Annotating and prioritizing genomic variants using the Ensembl Variant Effect Predictor—A tutorialHuman Mutation, 2021
- Survey of germline variants in cancer‐associated genes in young adults with colorectal cancerGenes, Chromosomes and Cancer, 2021
- Associations Between Cancer Predisposition Testing Panel Genes and Breast CancerJAMA Oncology, 2017
- Germline genetic variants in men with prostate cancer and one or more additional cancersCancer, 2017
- A study of over 35,000 women with breast cancer tested with a 25‐gene panel of hereditary cancer genesCancer, 2017
- Genetic heterogeneity in regional populations of Quebec—Parental lineages in the Gaspe PeninsulaAmerican Journal of Physical Anthropology, 2009
- Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5 BRCA1 and BRCA2 mutationsInternational Journal of Cancer, 2004
- Cancer in Fanconi anemia, 1927–2001Cancer, 2003